Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • C-peptide  (3)
  • Euglycaemic clamp  (2)
  • Obesity  (2)
  • 1
    ISSN: 1432-1440
    Keywords: Semisynthetic human insulin ; Biological potency ; Insulin hypoglycaemia ; Euglycaemic clamp
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary The biological potency of semisynthetic human insulin (Actrapid HM, Novo) and purified pork insulin (Actrapid MC, Novo) was assessed in normal and diabetic subjects. The blood glucose lowering effect and the related counter-regulatory response were initially tested in six healthy subjects who received an i.v. injection of 0.15 U/kg body weight of either insulin preparation. The attained insulin levels were very similar (peak at 15 min: HM 139±7, MC 129±7 µU/ml), as well as the resulting blood glucose curves. A prolonged suppression of C-peptide values was observed after injecting both preparations. The evoked counter-regulatory response [glucagon, growth hormone (GH), cortisol and catecholamines] showed minimal differences. Prolactin secretion was almost identical after HM and MC injection. A glucose clamp study was subsequently performed in six insulin-dependent diabetic (IDD) patients. Blood glucose levels were maintained at 80 mg/dl by the artificial pancreas during a 180 min infusion of MC or HM insulin (30 mU/kg/h). The amounts of dextrose infused during the last 60 min of the study were not significantly different (121±14 vs 137±11 mg/kg/h for MC and HM, respectively). It is clear from our results that at the dose levels used in this study, the biological potency of i.v. injected HM is very similar to that of MC.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    Springer
    Journal of molecular medicine 56 (1978), S. 111-120 
    ISSN: 1432-1440
    Keywords: C-peptide ; Diabetes mellitus ; Glibenclamide, therapeutic use ; Insulin secretion ; C-Peptid ; Diabetes mellitus ; Glibenclamid, therapeutische Anwendung ; Insulinsekretion
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Zusammenfassung Erwachsene Diabetiker wurden je nach Therapie vor und nach einem Behandlungsversuch mit Diät und Glibenclamid in 4 Gruppen eingeteilt: I: vorher Insulin — nachher Insulin, II: Tabletten — Insulin, III: Insulin — Tabletten und IV: Tabletten — Tabletten. Bei 6 Stoffwechselgesunden und 10 Patienten aus jeder Diabetikergruppe wurde die Sekretionskapazität der Beta-Zellen nach i.v. Belastung mit Glibenclamid-Glukose mittels C-Peptid Messungen untersucht. Bei den Diabetikern aller Gruppen kam eine Sekretionsstarre in einem verminderten und verzögerten Anstieg von immunologisch meßbarem C-Peptid (IMCP) zum Ausdruck. Bei tablettenbedürftigen Patienten hielt die Sekretion allerdings länger an als bei Stoffwechselgesunden. Im Mittel waren der Zuwachs von IMCP und die integrierten Stimulationsflächen bei tablettenbedürftigen Patienten (III+IV) viel größer als bei insulinbedürftigen (I+II). Eine Varianzanalyse wurde für die insulinbedürftigen Fälle einerseits und die tablettenbedürftigen Patienten andererseits durchgeführt. Die Gruppen I und II unterscheiden sich überzufällig bezüglich der Gruppenmittelwerte für IMCP, während der zeitliche Verlauf der IMCP Mittelwerte der beiden Gruppen nur zufällig von der Parallelität abweicht. In den Gruppen III und IV unterscheiden sich weder die Gruppenmittelwerte überzufällig, noch konnte eine Abweichung der jeweiligen zeitlichen Verläufe von der Parallelität nachgewiesen werden. Der zeitliche Verlauf konnte für Insulinbedürftige durch ein Regressionspolynom 2. Grades, für Tablettenbedürftige durch ein Regressionspolynom 4. Grades dargestellt werden. Die Kurven unterscheiden sich erheblich in Ausmaß und Steilheit ihres Anstiegs. Die Therapievorhersage nach i.v. Belastung mit Glibenclamid-Glukose, die bisher auf Kriterien des Blutglukoseverlaufs beruhte, ist bei Kenntnis des IMCP Verlaufs leichter und zuverlässiger möglich. Als natürlicher Verlauf des Diabetes mellitus im Erwachsenenalter ist die Entwicklung der Restsekretion der Beta-Zellen vom Stadium der Gruppen III und IV über Gruppe II zum Stadium der Gruppe I wahrscheinlich.
    Notes: Summary Adult diabetics were divided into 4 groups according to therapy before and after a therapeutic trial with diet and glibenclamide: I: insulin before — insulin afterwards, II: tablets — insulin, III: insulin — tablets and IV: tablets — tablets. The secretion capacity of the beta-cells, determined by C-peptide was examined in 6 healthy subjects and in 10 diabetics of each group following an i.v. glibenclamide-glucose load. A decreased insulinogenic reserve showing itself in a reduced and delayed rise of immunomeasurable C-peptide (IMCP) was found in all diabetics. However, the secretion of IMCP lasted longer in the diabetics requiring tablets than in the healthy subjects. The average values for the increment of IMCP and the integrated stimulation areas were much more considerable in the patients treated with tablets (III+IV) than in the insulin-dependent patients (I+II). An analysis of variance was performed for the diabetics depending on insulin, on the one hand, and the patients depending on tablets on the other. Between groups I and II the group average values for IMCP are significantly different while differences in the time course of the IMCP mean values of both groups are accidental. Neither the group average values of IMCP nor the time course of the IMCP mean values show significant differences between groups III and IV. The time course of IMCP was described by a regression polynomial of 2nd degree in insulin-dependent diabetics and a polynomial of 4th degree in diabetics depending on tablets; the corresponding curves differ considerably as to extent and steepness of their rise. Prediction of suitable diabetes therapy from an i.v. glibenclamide-glucose load based on blood glucose evaluation up to now is easier and more reliable since C-peptide levels are known. A development of the residual beta-cell function from the stage in groups III and IV via group II to the stage in group I is likely to be the natural course of adult diabetes.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    ISSN: 1432-0428
    Keywords: C-peptide ; insulin secretion ; effect of insulin ; alloxan-diabetic rats ; C-peptide effect in vivo ; somatostatin
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary The effects of synthetic rat C-peptide 1 and C-peptide 2 on plasma insulin and blood glucose concentrations in the rat were studied. Infusion of rat C-peptide (500μg·h-1· kg-1) diminished glucose induced increase of plasma insulin by 56% (15.2±0.9 versus 6.6± 0.6 ng/ml, p〈0.01, mean±SEM). Somatostatin infused at a rate of 50 μg·h-1·kg-1 body weight inhibited glucose-induced insulin secretion by 33%. In the presence of a mixture of both C-peptides or somatostatin, blood glucose after intravenous glucose was higher than in the control experiments. In alloxan-diabetic rats, C-peptide (160 μg/kg) significantly increased and prolonged the hypoglycaemic effect of exogenous insulin. It is suggested that C-peptide may not be a biologically inert substance.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    Electronic Resource
    Electronic Resource
    Springer
    Journal of molecular medicine 66 (1988), S. 216-222 
    ISSN: 1432-1440
    Keywords: Fat distribution ; Hyperinsulinemia ; Obesity ; Glucose tolerance ; Non-insulin dependent diabetes
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary Relationship between body fat distribution, serum insulin, and glucose tolerance in obese, non-diabetic women. Recent studies suggest that hyperinsulinemia and upper body obesity are predictive factors for the development of non-insulindependent diabetes mellitus. To further characterize the relationship between body fat distribution, serum insulin, and glucose tolerance an oral glucose tolerance test was performed in 48 obese, nondiabetic women. Fasting insulin levels were correlated to both total body fat calculated as body mass index (r=0.58,p〈0.001) and upper body fat distribution expressed as waist-to-hip ratio (WHR,r=0.47,p〈0.01). In the women with upper body fat localization (WHR〉0.90) significantly higher basal and glucose-stimulated insulin concentrations were established than in the women with a lower body type of obesity (WHR〈0.78) (basal insulin 27.4±11.5 vs. 15.4±8.8 mU/l,p〈0.05, insulin area 779±320 vs. 468±237 U,p〈0.05). They also had impaired glucose tolerance (glucose area 925±139 vs. 633±147 U,p〈0.01). Fasting triglyceride concentrations were correlated both with WHR (r=0.63,p〈0.001) and fasting insulin (r=0.33,p〈0.05) but not with BMI (r=−0.02, n.s.). A positive association was found between systolic and diastolic blood pressure and both WHR (r=0.43 andr=0.44 resp.,p〈0.01) and BMI (eachr=0.35,p〈0.05). Interestingly, basal insulin was also associated with blood pressure (r=0.30,p〈0.1, andr=0.40,p〈0.01 resp.). These results suggest a close relationship between upper body obesity, hyperinsulinemia, and impaired glucose tolerance. Women with an upper body tpye of obesity also show tendencies to hypertriglyceridemia and hypertension. Obese women with upper body obesity represent a subgroup of the obesity population with an increased risk to develop type-II diabetes.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    ISSN: 1432-1440
    Keywords: Somatostatin ; Insulin ; C-peptide ; Diabetes ; Pituitary function ; Gastric acid secretion
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary A case of somatostatinoma syndrome in a 30-year-old woman is presented. Basal levels of growth hormone and of pancreatic and gastric hormones were reduced and the response of growth hormone, insulin and C-peptide to stimuli such as arginine, glucose, glibenclamide and calcium was virtually abolished. Similarly, gastric acid secretion, pancreatic exocrine function and intestinal absorption were significantly reduced. On the other hand, basal and stimulated levels of adrenocorticotropic hormone (ACTH), luteinizing hormone (LH), follicle-stimulating hormone (FSH) and thyroid-stimulating hormone (TSH) were within the normal range. Plasma somatostatin-like immunoreactivity was increased to 600 2,000 pg/ml (normal: 88–140 pg/ml). Immunocytochemical studies demonstrated the presence of somatostatin immunoreactive material in the primary tumour in the head of the pancreas and in the liver metastases. In spite of two courses of chemotherapy with streptozotocin and 5-fluorouracil the patient died due to liver failure 5 months after the first admission to hospital.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 6
    Electronic Resource
    Electronic Resource
    Springer
    Journal of molecular medicine 63 (1985), S. 545-553 
    ISSN: 1432-1440
    Keywords: Type I diabetes ; Insulin resistance ; Euglycaemic clamp ; Insulin receptor binding ; Insulin antibodies
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary Insulin sensitivity was assessed using the euglycaemic clamp technique in eight type I diabetic patients (after overnight blood glucose normalization with an artificial pancreas) and in six healthy subjects. Basal insulin concentrations were higher in diabetic patients (25±4 µU/ml) than in control subjects (17±1 µU/ml;P〈0.05). Insulin infusion of 0.5, 1.0, 2.0 and 5.0 mU/kg per min during subsequent 2-h periods resulted in similar mean steady-state insulin concentrations in both groups. The mean dextrose requirements during the last 40 min of each period were nevertheless decreased in diabetic patients (1.6±0.5, 3.5±0.8, 6.5±0.7, 10.2±0.7 mg/kg per min) as compared with control subjects (4.7±0.3, 8.2±0.9, 10.2±0.9, 12.4±0.9 mg/kg per min). At low insulin concentrations dextrose requirements were diminished in all diabetic subjects. At the highest insulin levels, individual dose-response curves from only four patients were within the normal range. Under basal conditions, the monocyte receptor number was significantly reduced in diabetic patients (17,500±2,800 sites/cell) as compared with control subjects (26,700±2,500 sites/cell;P〈0.05), whereas there were no differences regarding empty site affinities. Receptor data did not differ in patients with normal and decreased maximal dextrose requirements. Insulin resistance is apparently a common feature of type I diabetes at serum insulin concentrations of approximately 100 µU/ml. Normalization of the insulin effect by higher insulin concentrations is not possible in all patients. Insulin antibodies at concentrations observed in this study (〈0.16 mU/ml) do not contribute significantly to insulin resistance; receptor and postreceptor defects are possibly more important.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 7
    ISSN: 1432-1440
    Keywords: Coronary artery disease ; Sex hormones ; Obesity ; Body fat distribution ; Angiography
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary The relationship between circulating sex hormone levels and the occurrence of coronary artery disease (CAD) was studied in a group of 274 men undergoing coronary angiography. Hormone levels in men with CAD (n=200) were compared to those in men found to be free of coronary lesions (n=74). No significant differences were found for serum concentrations of estradiol, total testosterone, sex-hormone-binding globulin, free androgen index, dehydroepiandrosterone sulfate, or cortisol between the two groups. Serum androgens were negatively correlated to age in both groups, whereas estradiol was weakly associated with total cholesterol in the group of men without CAD. No consistent associations were detected between sex hormone levels and the degree of obesity or the distribution of body fat, the latter being assessed by the ratio of waist-to-hip circumferences. The results of this study do not support a significant role of sex steroid hormones in coronary artery disease in men.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...